Lifestyle, Anthropometric, and Obesity-Related Physiologic Determinants of Insulin-like Growth Factor-1 in the Third National Health and Nutrition Examination Survey (1988-1994)

Annals of Epidemiology

Volumn 20, Issue 3, 2010, Pages 182-193

  Parekh, Niyati ^a   Roberts, Calpurnyia B ^b   Vadiveloo, Maya ^a   Puvananayagam, Thanusha ^b   Albu, Jeanine B ^c   Lu Yao, Grace L ^b,d,e  

^a NEW YORK UNIVERSITY   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^c College of Physicians and Surgeons ^*  (United States)

^d RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

Cancer; Determinants; IGF 1; Insulin Resistance; Lifestyle; Metabolic Syndrome

Indexed keywords

GLUCOSE; SOMATOMEDIN C;

ADULT; AGE; ANTHROPOMETRIC PARAMETERS; ANTHROPOMETRY; ARTICLE; BODY MASS; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HUMAN; HYPERGLYCEMIA; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SEX DIFFERENCE; WAIST CIRCUMFERENCE;

ADIPOSITY; ADULT; AGE FACTORS; ANTHROPOMETRY; BLOOD GLUCOSE; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERGLYCEMIA; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LIFE STYLE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 75949084809     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2009.11.008     Document Type: Article

References (56)

1. Juul A. Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Hormone IGF research 13 4 (2003) 113-170
2. Roberts D.L., Dive C., and Renehan A.G. Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Med Rev 61 (2010) 301-316
3. Renehan A.G., Harvie M., and Howell A. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk: eight years on. Endocr Relat Cancer 13 (2006) 273-278
4. Cruickshank J.K., Heald A.H., Anderson S., Cade J.E., Sampayo J., Riste L.K., et al. Epidemiology of the insulin-like growth factor system in three ethnic groups. Am J Epidemiol 154 (2001) 504-513
5. DeLellis K., Rinaldi S., Kaaks R.J., Kolonel L.N., Henderson B., and Le Marchand L. Dietary and lifestyle correlates of plasma insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGF BP-3): the multiethnic cohort. Cancer Epidemiol Biomarkers Prev 13 (2004) 1444-1451
6. Succurro E., Andreozzi F., Sciaqua A., Hribal M.L., Perticone F., and Sesti G. Reciprocal association of plasma IGF-1 and interleukin-6 levels with cardiometabolic risk factors in nondiabetic subjects. Diabetes Care 31 (2008) 1886-1888
7. Larsson S.C., Wolk K., Brismar K., and Wolk A. Association of diet with serum insulin-like growth factor I in middle-aged and elderly men. Am J Clin Nutr 81 (2005) 1163-1167
8. McGreevy K.M., Hoel B.D., Lipsitz S.R., and Hoel D.G. Impact of nutrients on insulin-like growth factor-I, insulin-like growth factor binding protein-3 and their ratio in African American and white males. Public Health Nutr 10 (2007) 97-105
9. Berrigan D., Potischman N., Dodd K.W., Hursting S.D., Lavigne J., Barrett J.C., et al. Race/ethnic variation in serum levels of IGF-I and IGFBP-3 in US adults. Growth Horm IGF Res 19 (2009) 146-155
10. Gapstur S.M., Kopp P., Chiu B.C., Gann P.H., Colangelo L.A., and Liu K. Longitudinal associations of age, anthropometric and lifestyle factors with serum total insulin-like growth factor-I and IGF binding protein-3 levels in black and white men: the CARDIA Male Hormone Study. Cancer Epidemiol Biomarkers Prev 13 (2004) 2208-2216
11. Landin-Wilhelmsen K., Lundberg P.A., Lappas G., and Wilhelmsen L. Insulin-like growth factor I levels in healthy adults. Horm Res 62 Suppl. 1 (2004) 8-16
12. Slattery M.L., Baumgartner K.B., Byers T., Guiliano A., Sweeney C., Herrick J., et al. Genetic, anthropometric, and lifestyle factors associated with IGF-1 and IGFBP-3 levels in Hispanic and non-Hispanic white women. Cancer Causes Control 16 (2005) 1147-1157
13. Holmes D., Pollak M.N., and Hankinson S.E. Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev 11 (2002) 862-867
14. Lukanova A., Toniolo P., Akhmedkhanov A., Hunt K., Rinaldi S., Zeleniuch-Jacquotte A., et al. A cross-sectional study of IGF-I determinants in women. Eur J Cancer Prev 10 (2001) 443-452
15. Smith A.T., Clemmons D.R., Underwood L.E., Ben-Ezra V., and McMurray R. The effect of exercise on plasma somatomedin-C/insulinlike growth factor I concentrations. Metabolism 36 (1987) 533-537
16. Probst-Hensch N.M., Wang H., Goh V.H., Seow A., Lee H.P., and Yu M.C. Determinants of circulating insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations in a cohort of Singapore men and women. Cancer Epidemiol Biomarkers Prev 12 (2003) 739-746
17. Goodman-Gruen D., and Barrett-Connor E. Epidemiology of insulin-like growth factor-I in elderly men and women. The Rancho Bernardo Study. Am J Epidemiol 145 (1997) 970-976
18. Sesti G., Sciacqua A., Cardellini M., Marini M.A., Maio R., Vatrano M., et al. Plasma concentration of IGF-I is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance. Diabetes Care 28 (2005) 120-125
19. Gram I.T., Norat T., Rinaldi S., Dossus L., Lukanova A., Tehard B., et al. Body mass index, waist circumference and waist-hip ratio and serum levels of IGF-I and IGFBP-3 in European women. Int J Obes (Lond) 30 (2006 Nov) 1623-1631
20. Allen N.E., Appleby P.N., Kaaks R., Rinaldi S., Davey G.K., and Key T.J. Lifestyle determinants of serum insulin-like growth-factor-I (IGF-I), C-peptide and hormone binding protein levels in British women. Cancer Causes Control 14 (2003) 65-74
21. Chang S., Wu X., Yu H., and Spitz M.R. Plasma concentrations of insulin-like growth factors among healthy adult men and postmenopausal women: associations with body composition, lifestyle, and reproductive factors. Cancer Epidemiol Biomarkers Prev 11 (2002) 758-766
22. Vrieling A., Voskuil D.W., Bueno de Mesquita H.B., Kaaks R., van Noord P.A., Keinan-Boker L., et al. Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands. Cancer Causes Control 15 (2004) 787-796
23. Ahmed R.L., Schmitz K.H., Anderson K.E., Rosamond W.D., and Folsom A.R. The metabolic syndrome and risk of incident colorectal cancer. Cancer 107 (2006) 28-36
24. Bowers K., Albanes D., Limburg P., Pietinen P., Taylor P.R., Virtamo J., et al. A prospective study of anthropometric and clinical measurements associated with insulin resistance syndrome and colorectal cancer in male smokers. Am J Epidemiol 164 (2006) 652-664
25. Lorincz A.M., and Sukumar S. Molecular links between obesity and breast cancer. Endocr Relat Cancer 13 (2006) 279-292
26. Lund Haheim L., Wisloff T.F., Holme I., and Nafstad P. Metabolic syndrome predicts prostate cancer in a cohort of middle-aged Norwegian men followed for 27 years. Am J Epidemiol 164 (2006) 769-774
27. Tande A.J., Platz E.A., and Folsom A.R. The metabolic syndrome is associated with reduced risk of prostate cancer. Am J Epidemiol 164 (2006) 1094-1102
28. Cowey S., and Hardy R.W. The metabolic syndrome: A high-risk state for cancer?. Am J Pathol 169 (2006) 1505-1522
29. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics. CA Cancer J Clin 2005 55 (2002) 74-108
30. Ogden C.L., Carroll M.D., Curtin L.R., McDowell M.A., Tabak C.J., and Flegal K.M. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295 (2006) 1549-1555
31. Hedley A.A., Ogden C.L., Johnson C.L., Carroll M.D., Curtin L.R., and Flegal K.M. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 291 (2004) 2847-2850
32. National Center of Health Statistics. Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988-1994. Hyattsville (MD). National Center of Health Statistics (1995)
33. Berrigan D., Potischman N., Dodd K.W., Nicar M., McQuillan G., Lavigne J.A., et al. Serum levels of insulin-like growth factor-I and insulin-like growth factor-I binding protein-3: quality control for studies of stored serum. Cancer Epidemiol Biomarkers Prev 16 (2007) 1017-1022
34. Ainsworth B.E., Haskell W.L., Leon A.S., Jacobs Jr. D.R., Montoye H.J., Sallis J.F., et al. Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 25 (1993) 71-80
35. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
36. O'Connor K.G., Tobin J.D., Harman S.M., Plato C.C., Roy T.A., Sherman S.S., et al. Serum levels of insulin-like growth factor-I are related to age and not to body composition in healthy women and men. J Gerontol A Biol Sci Med Sci 53 (1998) M176-M182
37. Rosen C.J. Serum insulin-like growth factors and insulin-like growth factor-binding proteins: clinical implications. Clin Chem 45 (1999) 1384-1390
38. Schoen R.E., Schragin J., Weissfeld J.L., Thaete F.L., Evans R.W., Rosen C.J., et al. Lack of association between adipose tissue distribution and IGF-1 and IGFBP-3 in men and women. Cancer Epidemiol Biomarkers Prev 11 (2002) 581-586
39. Juul A., Bang P., Hertel N.T., Main K., Dalgaard P., Jorgensen K., et al. Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 78 (1994) 744-752
40. Buongiorno A.M., Morelli S., Sagratella E., Sensi M., Maroccia E., Caiola S., et al. Influence of family history of type 2 diabetes on leptin concentration in cord blood of male offspring with high birth weight. Ann Ist Super Sanita 43 (2007) 77-82
41. Sandhu M.S., Gibson J.M., Heald A.H., Dunger D.B., and Wareham N.J. Association between insulin-like growth factor-I: insulin-like growth factor-binding protein-1 ratio and metabolic and anthropometric factors in men and women. Cancer Epidemiol Biomarkers Prev 13 (2004) 166-170
42. Lukanova A., Lundin E., Zeleniuch-Jacquotte A., Muti P., Mure A., Rinaldi S., et al. Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women. Eur J Endocrinol 150 (2004) 161-171
43. Lukanova A., Soderberg S., Stattin P., Palmqvist R., Lundin E., Biessy C., et al. Nonlinear relationship of insulin-like growth factor (IGF)-I and IGF-I/IGF-binding protein-3 ratio with indices of adiposity and plasma insulin concentrations (Sweden). Cancer Causes Control 13 (2002) 509-516
44. Saydah S., Ballard-Barbash R., and Potischman N. Association of metabolic syndrome with insulin-like growth factors among adults in the US. Cancer Causes Control (2009 May 5) Epub ahead of print
45. Schernhammer E.S., Tworoger S.S., Eliassen A.H., Missmer S.A., Holly J.M., Pollak M.N., et al. Body shape throughout life and correlations with IGFs and GH. Endocr Relat Cancer 14 (2007) 721-732
46. Gianotti L., Broglio F., Ramunni J., Lanfranco F., Gauna C., Benso A., et al. The activity of GH/IGF-I axis in anorexia nervosa and in obesity: a comparison with normal subjects and patients with hypopituitarism or critical illness. Eat Weight Disord 3 (1998) 64-70
47. Veldhuis J.D., and Iranmanesh A. Physiological regulation of the human growth hormone (GH)-insulin-like growth factor type I (IGF-I) axis: predominant impact of age, obesity, gonadal function, and sleep. Sleep 19 (1996) S221-S224
48. Kaaks R., and Lukanova A. Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc Nutr Soc 60 (2001) 91-106
49. Maccario M., Tassone F., Grottoli S., Rossetto R., Gauna C., and Ghigo E. Neuroendocrine and metabolic determinants of the adaptation of GH/IGF-I axis to obesity. Ann Endocrinol (Paris) 63 (2002) 140-144
50. Thissen J.P., Ketelslegers J.M., and Underwood L.E. Nutritional regulation of the insulin-like growth factors. Endocr Rev 15 (1994) 80-101
51. Pombo M., Pombo C.M., Astorga R., Cordido F., Popovic V., Garcia-Mayor R.V., et al. Regulation of growth hormone secretion by signals produced by the adipose tissue. J Endocrinol Invest 22 (1999) 22-26
52. Dossus L., and Kaaks R. Nutrition, metabolic factors and cancer risk. Best Pract Res Clin Endocrinol Metab 22 (2008) 551-571
53. Rajpathak S.N., Gunter M.J., Wylie-Rosett J., Ho G.Y., Kaplan R.C., Muzumdar R., et al. The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes. Diabetes Metab Res Rev 25 (2009) 3-12
54. Baxter R.C., Bryson J.M., and Turtle J.R. Somatogenic receptors of rat liver: regulation by insulin. Endocrinology 107 (1980) 1176-1181
55. Teramukai S., Rohan T., Eguchi H., Oda T., Shinchi K., and Kono S. Anthropometric and behavioral correlates of insulin-like growth factor I and insulin-like growth factor binding protein 3 in middle-aged Japanese men. Am J Epidemiol 156 (2002) 344-348
56. Felig P., and Wahren J. Fuel homeostasis in exercise. N Engl J Med 293 (1975) 1078-1084